SA PRO
Free Account
PVLAPVLA
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
9 analysts·Limited coverage
100%
Rating Distribution
Strong Buy
111%
Buy
889%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 133% higher.

Bear Case
$143.00
+79%
Consensus
$185.92
+133%
Bull Case
$210.00
+163%
Price Range9 analysts
Low
Consensus
High
$143.00
$210.00
Current Target
Current Price
$79.90
Upside to Target
$106.02

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 7, 2026Mizuho Securities
Palvella Therapeutics initiated with an Outperform at Mizuho
Target:$205.00
+126.7%from $90.43
Dec 16, 2025Canaccord Genuity
Palvella Therapeutics price target raised to $204 from $148 at Canaccord
Target:$204.00
+130.7%from $88.42
Dec 16, 2025Raymond James
Palvella Therapeutics (PVLA) PT Raised to $193 at Raymond James
Target:$193.00
+110.9%from $91.51
Dec 15, 2025Chardan Capital
Palvella Therapeutics price target raised to $174 from $110 at Chardan
Target:$174.00
+96.8%from $88.42
Dec 15, 2025BTIG
Palvella Therapeutics (PVLA) PT Raised to $192 at BTIG
Target:$192.00
+117.1%from $88.42
Dec 15, 2025Truist Financial
Palvella Therapeutics price target raised to $190 from $105 at Truist
Target:$190.00
+113.7%from $88.89
Dec 15, 2025UBS
Palvella Therapeutics (PVLA) PT Raised to $143 at Jones Trading
Target:$143.00
+61.7%from $88.42
Dec 15, 2025H.C. Wainwright
Palvella Therapeutics price target raised to $200 from $190 at H.C. Wainwright
Target:$200.00
+120.7%from $90.63
Dec 15, 2025Cantor Fitzgerald
Palvella price target raised to $210 from $200 at Cantor Fitzgerald
Target:$210.00
+136.7%from $88.72
Dec 15, 2025Oppenheimer
Palvella Therapeutics price target raised to $200 from $120 at Oppenheimer
Target:$200.00
+128.8%from $87.43
Dec 11, 2025H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Palvella Therapeutics (PVLA)
Target:$190.00
+96.8%from $96.55
Dec 5, 2025BTIG
Palvella Therapeutics initiated with a Buy at BTIG
Target:$167.00
+78.0%from $93.80
Dec 4, 2025Craig-Hallum
Palvella Therapeutics initiated with a Buy at Craig-Hallum
Target:$175.00
+90.4%from $91.91
Nov 24, 2025Stifel Nicolaus
Palvella Therapeutics (PVLA) PT Raised to $145 at Stifel
Target:$145.00
+54.1%from $94.09
Nov 19, 2025Raymond James
Palvella Therapeutics upgraded to Strong Buy from Outperform at Raymond James
Target:$143.00
+47.6%from $96.91
Nov 6, 2025Cantor Fitzgerald
Palvella Therapeutics price target raised to $200 from $120 at Cantor Fitzgerald
Target:$200.00
+146.7%from $81.08
Oct 9, 2025Canaccord Genuity
Palvella Therapeutics price target raised to $90 from $66 at Canaccord
Target:$90.00
+20.2%from $74.85
Oct 7, 2025Cantor Fitzgerald
Palvella Therapeutics price target raised to $120 from $70 at Cantor Fitzgerald
Target:$120.00
+68.1%from $71.38
Oct 2, 2025Truist Financial
Palvella Therapeutics price target raised to $80 from $56 at Truist
Target:$80.00
+29.7%from $61.69
Sep 25, 2025H.C. Wainwright
Palvella Therapeutics price target raised to $95 from $75 at H.C. Wainwright
Target:$95.00
+64.7%from $57.69
Sep 24, 2025Stifel Nicolaus
Palvella Therapeutics price target raised to $80 from $60 at Stifel
Target:$80.00
+33.6%from $59.87
Sep 9, 2025Oppenheimer
Palvella Therapeutics initiated with an Outperform at Oppenheimer
Target:$85.00
+49.9%from $56.71
Aug 15, 2025H.C. Wainwright
Palvella Therapeutics price target raised to $75 from $38 at H.C. Wainwright
Target:$75.00
+63.3%from $45.94
Aug 5, 2025Raymond James
Palvella Therapeutics initiated with an Outperform at Raymond James
Target:$54.00
+43.9%from $37.52
May 16, 2025Canaccord Genuity
Palvella Therapeutics price target lowered to $52 from $53 at Canaccord
Target:$52.00
+135.8%from $22.05

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance